David P Hochman
CIK 1292834 · View on SEC EDGAR ↗
First SEC filing: Jan. 30, 2023 · Latest: June 12, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 1, 2026 | OBIO | P | 5,000 | $3.83 | $19,150 | 1,064,029 Direct | +0.47% | Acquired | 42.8% (price as of 2026-08-20) |
| May 15, 2026 | OBIO | P | 5,000 | $3.77 | $18,850 | 1,059,029 Direct | +0.47% | Acquired | 45.1% (price as of 2026-08-20) |
| March 13, 2026 | OBIO | P | 10,000 | $4.29 | $42,900 | 1,086,467 Direct | +0.93% | Acquired | 27.5% (price as of 2026-08-20) |
| Nov. 14, 2025 | OBIO | P | 5,000 | $4.07 | $20,350 | 612,822 Direct | +0.82% | Acquired | 34.4% (price as of 2026-08-20) |
| Aug. 21, 2025 | OBIO | P | 6,000 | $2.49 | $14,940 | 651,460 Direct | +0.93% | Acquired | 119.7% (price as of 2026-08-20) |
| Aug. 4, 2025 | OBIO | P | 20,000 | $2.75 | $55,000 | 349,331 Indirect | +6.07% | Acquired | 98.9% (price as of 2026-08-20) |
| Dec. 23, 2024 | OBIO | P | 4,000 | $4.66 | $18,640 | 579,498 Direct | +0.70% | Acquired | 17.4% (price as of 2026-08-20) |
| Dec. 18, 2024 | OBIO | P | 5,000 | $4.91 | $24,550 | 575,498 Direct | +0.88% | Acquired | 11.4% (price as of 2026-08-20) |
| Sept. 25, 2024 | OBIO | P | 2,000 | $4.73 | $9,460 | 2,000 Indirect | — | Acquired | 15.6% (price as of 2026-08-20) |
| Sept. 25, 2024 | OBIO | P | 2,000 | $4.70 | $9,400 | 2,000 Indirect | — | Acquired | 16.4% (price as of 2026-08-20) |
| Sept. 25, 2024 | OBIO | P | 2,000 | $4.74 | $9,480 | 2,000 Indirect | — | Acquired | 15.4% (price as of 2026-08-20) |
| Sept. 25, 2024 | OBIO | P | 1,500 | $4.86 | $7,290 | 335,002 Indirect | +0.45% | Acquired | 12.6% (price as of 2026-08-20) |
| Sept. 24, 2024 | OBIO | P | 2,500 | $4.91 | $12,275 | 570,498 Direct | +0.44% | Acquired | 11.4% (price as of 2026-08-20) |
| Aug. 14, 2024 | OBIO | P | 2,500 | $5.84 | $14,600 | 567,998 Direct | +0.44% | Acquired | -6.3% (price as of 2026-08-20) |
| June 25, 2024 | OBIO | P | 1,000 | $6.95 | $6,950 | 333,502 Indirect | +0.30% | Acquired | -21.3% (price as of 2026-08-20) |
| May 17, 2024 | OBIO | P | 3,000 | $5.15 | $15,450 | 332,502 Indirect | +0.91% | Acquired | 6.2% (price as of 2026-08-20) |
| May 16, 2024 | OBIO | P | 2,000 | $4.75 | $9,500 | 329,502 Indirect | +0.61% | Acquired | 15.2% (price as of 2026-08-20) |
| March 15, 2019 | CRBP | P | 2,000 | $6.98 | $13,960 | 7,000 Indirect | +40.00% | Acquired | -95.3% (price as of 2026-08-20) |
| May 14, 2018 | CRBP | P | 5,000 | $5.48 | $27,400 | 5,000 Indirect | — | Acquired | -94.0% (price as of 2026-08-20) |
| March 14, 2018 | CRBP | P | 5,000 | $6.66 | $33,300 | 225,000 Indirect | +2.27% | Acquired | -95.1% (price as of 2026-08-20) |
| Nov. 15, 2017 | CRBP | P | 5,000 | $6.55 | $32,750 | 220,000 Indirect | +2.33% | Acquired | -95.0% (price as of 2026-08-20) |
| Nov. 13, 2017 | CRBP | P | 5,000 | $6.90 | $34,500 | 215,000 Indirect | +2.38% | Acquired | -95.2% (price as of 2026-08-20) |
| Nov. 10, 2017 | CRBP | P | 10,000 | $7.08 | $70,800 | 459,500 Direct | +2.22% | Acquired | -95.4% (price as of 2026-08-20) |
| May 11, 2017 | CRBP | P | 3,400 | $6.18 | $21,012 | 459,500 Direct | +0.75% | Acquired | -94.7% (price as of 2026-08-20) |
| Nov. 18, 2016 | CRBP | P | 10,000 | $7.00 | $70,000 | 456,100 Direct | +2.24% | Acquired | -95.3% (price as of 2026-08-20) |
| Aug. 17, 2015 | CRBP | P | 1,000 | $1.92 | $1,920 | 454,300 Direct | +0.22% | Acquired | -82.9% (price as of 2026-08-20) |
| Dec. 4, 2014 | CRBP | P | 1,300 | $3.05 | $3,965 | 443,300 Direct | +0.29% | Acquired | -89.2% (price as of 2026-08-20) |
| Dec. 2, 2014 | CRBP | P | 500 | $3.50 | $1,750 | 442,000 Direct | +0.11% | Acquired | -90.6% (price as of 2026-08-20) |
| Dec. 2, 2014 | CRBP | P | 400 | $3.25 | $1,300 | 441,500 Direct | +0.09% | Acquired | -89.9% (price as of 2026-08-20) |
| Dec. 1, 2014 | CRBP | P | 500 | $4.00 | $2,000 | 441,100 Direct | +0.11% | Acquired | -91.8% (price as of 2026-08-20) |
| Nov. 25, 2014 | CRBP | P | 500 | $3.09 | $1,545 | 440,600 Direct | +0.11% | Acquired | -89.4% (price as of 2026-08-20) |
| Nov. 25, 2014 | CRBP | P | 1,500 | $3.08 | $4,620 | 440,100 Direct | +0.34% | Acquired | -89.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 4, 2025 | OBIO | Stock Option (Right to Buy) | Common Stock (147,500) | $2.76 | April 4, 2035 | 147,500 | Acquired |
| July 20, 2023 | OBIO | Stock Option (Right to Buy) | Common Stock (132,000) | $7.42 | July 20, 2033 | 132,000 | Acquired |
| July 20, 2023 | OBIO | Stock Option (Right to Buy) | Common Stock (100,500) | $7.42 | July 20, 2033 | 100,500 | Acquired |
| April 12, 2023 | OBIO | Right to Receive Earnout Shares | Common Stock (683) | — | — | 683 | Disposed |
| April 12, 2023 | OBIO | Right to Receive Earnout Shares | Common Stock (11,160) | — | — | 11,160 | Disposed |
| April 12, 2023 | OBIO | Right to Receive Earnout Shares | Common Stock (29,551) | — | — | 29,551 | Disposed |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) [F1] | Common Stock (116,250) | $10.00 | Jan. 19, 2033 | 116,250 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) [F1] | Common Stock (208,216) | $10.00 | Aug. 17, 2032 | 208,216 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) [F1] | Common Stock (300,181) | $10.00 | Aug. 17, 2032 | 300,181 | Acquired |
| Jan. 26, 2023 | OBIO | Right to Receive Earnout Shares [F1] | Common Stock (1,366) | — | — | 1,366 | Acquired |
| Jan. 26, 2023 | OBIO | Right to Receive Earnout Shares [F1] | Common Stock (22,320) | — | — | 22,320 | Acquired |
| Jan. 26, 2023 | OBIO | Right to Receive Earnout Shares [F1] | Common Stock (59,102) | — | — | 59,102 | Acquired |
| Jan. 26, 2023 | OBIO | Warrant (Right to Buy) | Common Stock (410) | $21.51 | May 31, 2023 | 410 | Acquired |
| Jan. 26, 2023 | OBIO | Warrant (Right to Buy) | Common Stock (422) | $21.51 | May 31, 2023 | 422 | Acquired |
| Jan. 26, 2023 | OBIO | Incentive Stock Option (Right to Buy) | Common Stock (6,743) | $4.06 | April 11, 2032 | 6,743 | Acquired |
| Jan. 26, 2023 | OBIO | Incentive Stock Option (Right to Buy) | Common Stock (69,750) | $4.30 | Aug. 7, 2028 | 69,750 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) | Common Stock (116,250) | $10.00 | Jan. 19, 2023 | 116,250 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) | Common Stock (208,216) | $10.00 | Aug. 25, 2032 | 208,216 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) | Common Stock (300,181) | $10.00 | Aug. 25, 2032 | 300,181 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) | Common Stock (31,000) | $4.06 | April 11, 2032 | 31,000 | Acquired |
| Jan. 26, 2023 | OBIO | Nonstatutory Stock Option (Right to Buy) | Common Stock (194,071) | $4.30 | Aug. 7, 2028 | 194,071 | Acquired |
| May 20, 2020 | CRBP | Stock Option(right to buy) | Common Stock (40,500) | $7.30 | May 20, 2030 | 40,500 | Acquired |
| May 22, 2019 | CRBP | Stock Option(right to buy) | Common Stock (33,300) | $7.31 | May 22, 2029 | 33,300 | Acquired |
| May 24, 2018 | CRBP | Stock Option(right to buy) [F3] | Common Stock (34,000) | $5.93 | May 24, 2028 | 34,000 | Acquired |
| May 25, 2017 | CRBP | Stock Option(right to buy) | Common Stock (30,500) | $6.75 | May 25, 2027 | 30,500 | Acquired |
| Sept. 16, 2016 | CRBP | Stock Option(right to buy) | Common Stock (50,000) | $7.14 | Sept. 16, 2026 | 50,000 | Acquired |
| May 26, 2016 | CRBP | Stock Option(right to buy) | Common Stock (50,000) | $3.00 | May 26, 2026 | 50,000 | Acquired |
| Aug. 12, 2015 | CRBP | Stock Option(right to buy) | Common Stock (20,000) | $1.97 | Aug. 12, 2015 | 20,000 | Acquired |
| June 12, 2015 | CRBP | Warrant | Common Stock (50,000) | $1.00 | April 11, 2019 | 50,000 | Disposed |
| June 12, 2015 | CRBP | Warrant | Common Stock (10,000) | $1.00 | May 30, 2019 | 10,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 9 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 30, 2023 | OBIO | Warrants (Right to Buy)→ Common Stock, par value $0.0001 per share ("Common Stock") (225,000) | 225,000 | Direct |
| Nov. 25, 2014 | CRBP | Common Stock | 438,600 | Direct |
| Nov. 25, 2014 | CRBP | Common Stock | 4,300 | Indirect |
| Nov. 25, 2014 | CRBP | Common Stock | 4,300 | Indirect |
| Nov. 25, 2014 | CRBP | Common Stock | 4,300 | Indirect |
| Nov. 25, 2014 | CRBP | Common Stock | 140,000 | Indirect |
| Nov. 25, 2014 | CRBP | Warrant→ Common Stock (10,000) | 10,000 | Direct |
| Nov. 25, 2014 | CRBP | Warrant→ Common Stock (50,000) | 50,000 | Indirect |
| Nov. 25, 2014 | CRBP | Stock Option→ Common Stock (50,000) | 50,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $595,000 | — | $791,399 | $290,575 | $572,009 | — | $12,250 | $2,261,233 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.